REMS Integration Into Electronic Health Records To Be Tested By US FDA In Software Pilot
Executive Summary
The prototype pulls information from the electronic record to fill out enrollment and other forms, but stakeholders say it must work for most, if not all, REMS drugs in order to be widely used.
You may also be interested in...
FDA Real-Time Surveillance Not Practical For All Drugs, CDER’s Safety Surveillance Chief Says
Gerald Dal Pan indicated in an interview that the agency's safety systems as now constituted are generating the data needed and that so-called real-time surveillance, which is in place for COVID-19 vaccines and therapeutics, is not practical for all approved products.
iPLEDGE REMS: US FDA Advisory Cmte. Supports Relaxing Restrictions But Wants More Data
Panel favors elimination of 19-day lockout after patients who can become pregnant miss the first prescription pickup and continuation of at-home pregnancy tests. Members call for more data from isotretinoin sponsors on why acne patients are not participating in pregnancy registry and on disparities by race and ethnicity.
US FDA: Please Pay PDUFA Program Fees ASAP
Carryover funds are limited after the agency's collections schedule was altered by the late user fee program renewal.